Timing of Adverse Events Following Geriatric Hip Fracture Surgery: A Study of 19,873 Patients in the American College of Surgeons National Surgical Quality Improvement Program
Authors’ Disclosure Statement: The authors report no actual or potential conflict of interest in relation to this article.
Dr. Bohl and Dr. Basques are Orthopaedic Surgery Residents, Department of Orthopaedic Surgery, Rush University Medical Center, Chicago, Illinois. Dr. Samuel and Dr. Ondeck are Orthopaedic Surgery Residents, Department of Orthopaedic Surgery, Hospital for Special Surgery, New York, New York. Dr. Webb is an Orthopaedic Surgery Resident, Department of Orthopaedic Surgery, University of Pennsylvania, Philadelphia, Pennsylvania. Dr. Lukasiewicz is an Orthopaedic Surgery Resident, Mr. Anandasivam is a Research Fellow, and Dr. Grauer is a Professor, Department of Orthopaedics and Rehabilitation, Yale School of Medicine, New Haven, Connecticut.
Address correspondence to: Jonathan N. Grauer, MD, Department of Orthopaedics and Rehabilitation, Yale School of Medicine, 800 Howard Ave, New Haven, CT 06510 (tel, 203-737-7463; fax, 203-785-7132; email, jonathan.grauer@yale.edu).
Daniel D. Bohl, MD, MPH Andre M. Samuel, MD Matthew L. Webb, MDAdam M. Lukasiewicz, MD Nathaniel T. Ondeck, MD Bryce A. Basques, MD Nidharshan S. Anandasivam, BS Jonathan N. Grauer, MD . Timing of Adverse Events Following Geriatric Hip Fracture Surgery: A Study of 19,873 Patients in the American College of Surgeons National Surgical Quality Improvement Program. Am J Orthop.
September 27, 2018
References
METHODS
A retrospective analysis of data collected prospectively through the ACS-NSQIP was conducted. Geriatric patients who underwent hip fracture surgery during 2010 to 2013 were identified. Specific inclusion criteria were (1) International Classification of Diseases, Ninth Revision, diagnosis code 820, (2) primary Current Procedural Terminology codes 27125, 27130, 27235, 27236, 27244, or 27245, and (3) age ≥70 years.
The ACS-NSQIP captures patient demographic, comorbidity, and procedural characteristics at baseline.22 At the end of the 30-day follow-up period, the ACS-NSQIP personnel review both inpatient and outpatient charts to characterize the occurrence vs nonoccurrence of specific postoperative adverse events.22-25 When an adverse event does occur, the postoperative day of diagnosis is recorded.
For this study, the following adverse event categories were investigated: myocardial infarction, cardiac arrest requiring cardiopulmonary resuscitation, stroke, pneumonia, pulmonary embolism, urinary tract infection, deep vein thrombosis, sepsis (either with or without shock), mortality, and surgical site infection (including superficial surgical site infection, deep surgical site infection, and organ or space surgical site infection). Detailed definitions of each adverse event are provided in ACS-NSQIP materials.22
First, the 30-day incidence (and the associated 95% confidence interval) was determined for each adverse event. Second, the median postoperative day of diagnosis (and the associated interquartile range) was determined for each adverse event. Third, the postoperative length of stay was used to estimate the proportion of diagnoses occurring prior to vs following discharge for each adverse event. Finally, multivariate Cox proportional hazards models were used to identify independent risk factors for earlier occurrence of postoperative adverse events. The final models were selected using a backward stepwise process that sequentially eliminated variables with the weakest associations until all variables had P < .05.
Because the ACS-NSQIP reports timing data in calendar days, when the postoperative length of stay was equivalent to the postoperative day of diagnosis, it was not possible to ascertain whether the diagnosis occurred prior to or following discharge. For this study, when the postoperative length of stay was equivalent to the postoperative day of diagnosis, the adverse event was considered to have been diagnosed following discharge. The rationale for this is that for most of the adverse events, it was thought to be unlikely that an inpatient would be discharged before the end of the same day as an inpatient diagnosis. However, there was one exception to this rule; when the postoperative day of discharge, the postoperative length of stay, and the postoperative day of death were all equivalent, the adverse event was considered to have occurred prior to discharge. This is because when a patient dies during the initial inpatient stay, the ACS-NSQIP considers the postoperative length of stay to be equivalent to the postoperative day of death. This makes it much more likely that a diagnosis on the final hospital day had occurred in a patient who had not been discharged.
The mandatory ACS-NSQIP statement is “The American College of Surgeons National Surgical Quality Improvement Program and the hospitals participating in the ACS-NSQIP are the source of the data used herein; they have not verified and are not responsible for the statistical validity of the data analysis or the conclusions derived by the authors.”26